An Imaging Pilot Study of 18F-fluoro-3'-Deoxy-3'-L-fluorothymidine (18F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00414570
Recruitment Status : Unknown
Verified March 2016 by AHS Cancer Control Alberta.
Recruitment status was:  Recruiting
First Posted : December 21, 2006
Last Update Posted : March 16, 2016
Cross Cancer Institute
Information provided by (Responsible Party):
AHS Cancer Control Alberta

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : October 2016
  Estimated Study Completion Date : October 2016